Your browser is no longer supported. Please, upgrade your browser.
TFX [NYSE]
Teleflex Incorporated
IndexS&P 500 P/E67.88 EPS (ttm)5.90 Insider Own0.20% Shs Outstand46.70M Perf Week-2.90%
Market Cap18.50B Forward P/E26.90 EPS next Y14.90 Insider Trans-6.09% Shs Float46.40M Perf Month-6.00%
Income279.50M PEG6.17 EPS next Q2.87 Inst Own92.90% Short Float1.06% Perf Quarter0.11%
Sales2.54B P/S7.28 EPS this Y-27.60% Inst Trans-0.08% Short Ratio2.44 Perf Half Y19.28%
Book/sh72.29 P/B5.54 EPS next Y16.68% ROA4.10% Target Price473.36 Perf Year15.33%
Cash/sh7.03 P/C57.00 EPS next 5Y11.00% ROE8.60% 52W Range312.33 - 449.38 Perf YTD-2.64%
Dividend1.36 P/FCF45.68 EPS past 5Y7.60% ROI6.90% 52W High-10.83% Beta1.18
Dividend %0.34% Quick Ratio1.70 Sales past 5Y7.00% Gross Margin52.60% 52W Low28.30% ATR9.10
Employees14000 Current Ratio2.70 Sales Q/Q0.50% Oper. Margin14.50% RSI (14)35.23 Volatility2.18% 2.05%
OptionableYes Debt/Eq0.70 EPS Q/Q-43.10% Profit Margin11.00% Rel Volume1.10 Prev Close407.64
ShortableYes LT Debt/Eq0.68 EarningsApr 29 BMO Payout22.70% Avg Volume201.72K Price400.72
Recom1.60 SMA20-6.10% SMA50-4.15% SMA2003.68% Volume221,710 Change-1.70%
Jan-06-21Reiterated Needham Buy $406 → $445
Nov-02-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $382
Jan-31-20Reiterated Needham Buy $408 → $423
Aug-02-19Reiterated Needham Buy $325 → $403
Jun-11-19Initiated Wells Fargo Outperform $345
Apr-24-19Downgrade Needham Strong Buy → Buy $325
Feb-22-19Reiterated Needham Strong Buy $300 → $325
Oct-16-18Initiated Barclays Equal Weight $266
Sep-10-18Upgrade Needham Buy → Strong Buy $279 → $300
Aug-03-18Reiterated Needham Buy $298 → $279
May-14-18Reiterated Needham Buy $293 → $298
May-04-18Reiterated Needham Buy $285 → $293
Apr-04-18Initiated Goldman Neutral $257
Nov-10-17Resumed Piper Jaffray Overweight $295
Nov-03-17Reiterated Needham Buy $237 → $285
Sep-08-17Upgrade Leerink Partners Mkt Perform → Outperform
Sep-06-17Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-06-17Reiterated Needham Buy $228 → $237
Mar-07-17Initiated Needham Buy $221
Jan-06-17Upgrade Jefferies Hold → Buy
May-11-21 06:30AM  
May-03-21 04:30PM  
06:30AM  
Apr-30-21 10:22AM  
Apr-29-21 08:05AM  
06:30AM  
Apr-27-21 06:30AM  
Apr-23-21 07:52AM  
Apr-22-21 12:33PM  
Apr-15-21 06:30AM  
Apr-14-21 12:18PM  
Apr-12-21 06:10PM  
Apr-01-21 09:06AM  
Mar-27-21 11:31AM  
Mar-11-21 02:00AM  
Mar-10-21 06:30AM  
Mar-09-21 06:30AM  
Mar-02-21 07:35AM  
Feb-26-21 10:16AM  
Feb-25-21 09:00PM  
06:45AM  
06:30AM  
Feb-24-21 06:30AM  
Feb-23-21 06:30AM  
Feb-17-21 06:30AM  
Feb-16-21 06:30AM  
06:30AM  
Feb-11-21 06:30AM  
Jan-28-21 04:04AM  
Jan-20-21 06:30AM  
Jan-19-21 06:30AM  
Jan-04-21 06:30AM  
Dec-30-20 08:04AM  
Dec-29-20 06:01AM  
Dec-28-20 05:22PM  
05:00PM  
Dec-15-20 02:24PM  
Dec-08-20 12:26PM  
Dec-03-20 06:30AM  
Dec-02-20 05:14AM  
Nov-19-20 06:30AM  
Nov-17-20 10:03AM  
Nov-03-20 08:29AM  
Nov-02-20 11:29AM  
06:30AM  
Oct-29-20 07:45AM  
07:45AM  
06:45AM  
06:30AM  
Oct-28-20 05:00PM  
09:53AM  
06:30AM  
Oct-27-20 06:30AM  
Oct-22-20 12:33PM  
Oct-19-20 06:30AM  
Oct-08-20 06:30AM  
Oct-07-20 12:30PM  
Oct-05-20 09:59AM  
Oct-01-20 06:30AM  
Sep-28-20 10:54AM  
Sep-11-20 03:07PM  
Sep-02-20 06:30AM  
Aug-29-20 11:32AM  
Aug-26-20 06:30AM  
Aug-24-20 01:12PM  
10:28AM  
Aug-18-20 06:30AM  
Jul-31-20 12:41PM  
Jul-30-20 06:00PM  
08:15AM  
06:45AM  
06:30AM  
06:00AM  
Jul-23-20 12:33PM  
Jul-21-20 06:30AM  
Jul-20-20 06:30AM  
Jul-14-20 06:30AM  
Jul-09-20 06:05PM  
Jun-23-20 06:30AM  
Jun-22-20 06:30AM  
Jun-17-20 11:20AM  
Jun-08-20 05:00PM  
Jun-05-20 12:17PM  
Jun-04-20 10:07AM  
Jun-03-20 06:45AM  
Jun-02-20 06:30AM  
May-30-20 11:31AM  
May-27-20 10:10AM  
May-21-20 05:00PM  
10:49AM  
08:49AM  
May-20-20 02:35PM  
May-18-20 06:30AM  
May-04-20 10:55AM  
06:45AM  
06:30AM  
Apr-30-20 06:30PM  
07:55AM  
06:30AM  
Apr-29-20 05:15PM  
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hicks Cameron PCorp. VP & Chief HR OfficerMar 15Option Exercise103.073,326342,80611,604Mar 17 05:30 PM
Hicks Cameron PCorp. VP & Chief HR OfficerMar 15Sale421.013,0001,263,0408,604Mar 17 05:30 PM
Leyden James JVP, General Counsel, SecretaryDec 28Option Exercise99.0125,9962,573,83541,502Dec 29 06:49 PM
Hicks Cameron PCorp. VP, HR & CommunicationsDec 02Option Exercise110.261,088119,9599,245Dec 02 05:02 PM
Hicks Cameron PCorp. VP, HR & CommunicationsNov 30Option Exercise85.542,985255,33711,142Dec 02 05:02 PM
Hicks Cameron PCorp. VP, HR & CommunicationsNov 30Sale371.002,9851,107,4358,157Dec 02 05:02 PM
Klasko Stephen K. M.D.DirectorOct 26Option Exercise58.2520011,6501,321Oct 28 08:24 AM
Klasko Stephen K. M.D.DirectorOct 26Sale361.3820072,2761,121Oct 28 08:24 AM
Klasko Stephen K. M.D.DirectorSep 25Option Exercise58.2520011,6501,321Sep 28 09:27 PM
Klasko Stephen K. M.D.DirectorSep 25Sale326.1520065,2301,121Sep 28 09:27 PM
Klasko Stephen K. M.D.DirectorAug 25Option Exercise58.2520011,6501,321Aug 26 04:41 PM
Klasko Stephen K. M.D.DirectorAug 25Sale373.7420074,7481,121Aug 26 04:41 PM
Klasko Stephen K. M.D.DirectorJul 27Option Exercise58.2520011,6501,321Jul 28 09:05 PM
Klasko Stephen K. M.D.DirectorJul 27Sale386.3520077,2701,121Jul 28 09:05 PM
Klasko Stephen K. M.D.DirectorJun 25Option Exercise58.2520011,6501,321Jun 26 04:41 PM
Klasko Stephen K. M.D.DirectorMay 26Option Exercise58.2520011,6501,321May 27 04:35 PM
Klasko Stephen K. M.D.DirectorMay 26Sale375.1420075,0281,121May 27 04:35 PM